We are live on
!
Find out more
PAMU
Pictet Asset Management (UK) Portfolio holdings
AUM
$91.8B
1-Year Est. Return
47.77%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+47.77%
3 Year Est. Return
+102.96%
5 Year Est. Return
+189.45%
10 Year Est. Return
–
AUM
$40.5B
AUM Growth
+$1.67B
(+4.3%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
11.99%
Holding
924
New
37
Increased
379
Reduced
384
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$154M |
| 2 |
PayPal
PYPL
|
+$129M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$119M |
| 4 |
Union Pacific
UNP
|
+$105M |
| 5 |
Meta Platforms (Facebook)
META
|
+$82.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Company
SO
|
+$105M |
| 2 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$92.4M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$88.9M |
| 4 |
Intel
INTC
|
+$71.2M |
| 5 |
Amazon
AMZN
|
+$58.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.01% |
| 2 | Healthcare | 18.64% |
| 3 | Industrials | 12.41% |
| 4 | Consumer Discretionary | 10.04% |
| 5 | Utilities | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
326
DELISTED
Aerie Pharmaceuticals
AERI
| $28.3M | 0.07% |
521,992
+203,828
| +64% | +$11.4M |
|
|
IMPV
327
DELISTED
Imperva, Inc.
IMPV
| $28M | 0.07% |
646,697
+136,449
| +27% | +$6.13M |
|
328
Valero Energy
VLO
$93.3B
| $28M | 0.07% |
301,297
-80,562
| -21% | -$7.52M |
|
329
Occidental Petroleum
OXY
$59B
| $27.8M | 0.07% |
427,544
-9,800
| -2% | -$685K |
|
|
FRTA
330
DELISTED
Forterra, Inc
FRTA
| $27.4M | 0.07% |
3,294,306
+331,789
| +11% | +$2.83M |
|
|
BLUE
331
DELISTED
bluebird bio
BLUE
| $27.2M | 0.07% |
12,286
-399
| -3% | -$1.01M |
|
332
CSX Corp
CSX
$92.5B
| $27.1M | 0.07% |
1,460,562
-102,207
| -7% | -$1.91M |
|
|
FOLD
333
DELISTED
Amicus Therapeutics
FOLD
| $27M | 0.07% |
+1,794,997
| New | +$27.3M |
|
334
iShares TIPS Bond ETF
TIP
$14.7B
| $26.8M | 0.07% |
237,165
-158,535
| -40% | -$17.8M |
|
335
PPG Industries
PPG
$25.8B
| $26.7M | 0.07% |
239,494
+85,451
| +55% | +$9.87M |
|
336
Iron Mountain
IRM
$36.4B
| $26.6M | 0.07% |
809,684
-431,601
| -35% | -$14.5M |
|
337
Louisiana-Pacific
LPX
$5.28B
| $26.6M | 0.07% |
924,498
+811,246
| +716% | +$23.3M |
|
338
Prologis
PLD
$133B
| $26.5M | 0.07% |
421,381
+107,500
| +34% | +$6.68M |
|
|
TPH
339
DELISTED
Tri Pointe Homes
TPH
| $26.4M | 0.07% |
1,608,701
+728,034
| +83% | +$12.5M |
|
|
ATVI
340
DELISTED
Activision Blizzard
ATVI
| $25.9M | 0.06% |
383,305
-7,262
| -2% | -$513K |
|
341
Yum China
YUMC
$16.3B
| $25.2M | 0.06% |
606,500
-93,101
| -13% | -$4M |
|
|
SCG
342
DELISTED
Scana
SCG
| $25.1M | 0.06% |
669,562
-847,846
| -56% | -$34M |
|
343
Atmos Energy
ATO
$28.6B
| $25M | 0.06% |
296,549
-27,409
| -8% | -$2.23M |
|
344
HCA Healthcare
HCA
$89.1B
| $24.7M | 0.06% |
254,137
-21,400
| -8% | -$2.08M |
|
345
General Motors
GM
$78.4B
| $24.5M | 0.06% |
674,354
-24,700
| -4% | -$1M |
|
346
Credicorp
BAP
$30B
| $24.3M | 0.06% |
107,084
-900
| -0.8% | -$200K |
|
|
ARRY
347
DELISTED
Array Biopharma Inc
ARRY
| $24.2M | 0.06% |
1,481,131
+1,225,631
| +480% | +$19.6M |
|
348
AGCO
AGCO
$7.1B
| $24.1M | 0.06% |
371,435
+48,979
| +15% | +$3.38M |
|
349
Public Storage
PSA
$60.7B
| $23.7M | 0.06% |
118,110
+10,080
| +9% | +$1.96M |
|
350
Bright Horizons
BFAM
$3.76B
| $23.6M | 0.06% |
236,259
+23,776
| +11% | +$2.31M |
|
Similar funds
QI
FRBONY
ICOM
BAIA
BPB
BAPIM
PWA
UR
Pictet Asset Management (UK)'s Q1 2018 Portfolio in Review
As of Q1 2018, Pictet Asset Management (UK) held 924 positions worth $40.5B, up 4.3% from $38.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Pictet Asset Management (UK) deployed $1.77B of net new capital in Q1 2018, opening 37 new positions and adding to 379 existing holdings. Its largest new stake was Nektar Therapeutics: 32,593 shares worth $52M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Southern Company, an estimated $105M trimmed.
- Pictet Asset Management (UK)'s largest Q1 2018 buy was Nektar Therapeutics: 32,593 shares worth $52M.
- Pictet Asset Management (UK) added most to Lam Research in Q1 2018, an estimated $154M increase.
- Pictet Asset Management (UK)'s biggest Q1 2018 reduction was Southern Company, cutting an estimated $105M.
- Pictet Asset Management (UK) fully exited Deltic Timber in Q1 2018, selling an estimated $38.8M.
- Pictet Asset Management (UK)'s ten largest holdings make up 12% of its $40.5B portfolio in Q1 2018.
- Pictet Asset Management (UK) opened 37 new positions and closed 31 in Q1 2018.
- Pictet Asset Management (UK)'s portfolio value rose 4.3% quarter-over-quarter to $40.5B.
Based on Pictet Asset Management (UK)'s 13F filing for Q1 2018, filed 25 Apr 2018.